Glycopyrrolate

NDC 76045-208 · Fresenius Kabi USA, LLC

Generic nameGlycopyrrolate

Dosage formINJECTION, SOLUTION

RouteINTRAMUSCULAR, INTRAVENOUS

Active ingredient(s)GLYCOPYRROLATE

Strength.2 mg/mL

Pharmacologic classAnticholinergic [EPC], Cholinergic Antagonists [MoA]

Marketing categoryANDA

Packages

76045-208-20 — 24 BLISTER PACK in 1 CARTON (76045-208-20) / 1 SYRINGE, GLASS in 1 BLISTER PACK (76045-208-02) / 2 mL in 1 SYRINGE, GLASS

J1596 — Injection, glycopyrrolate, 0.1 mg Medicare Part B payment limit (ASP + 6%): $0.36

FDA lists these products with the same active ingredient.

72572-225 — Glycopyrrolate, 72572-226 — Glycopyrrolate, 72603-240 — Glycopyrrolate, 72887-160 — GLYCOPYRROLATE, 75834-193 — glycopyrrolate, 75834-194 — glycopyrrolate, 75834-195 — glycopyrrolate, 75834-196 — glycopyrrolate, 76045-023 — Glycopyrrolate, 76045-203 — Glycopyrrolate, 76045-206 — Glycopyrrolate, 76045-223 — Glycopyrrolate, 79739-7097 — Glycopyrrolate, 80056-160 — Glycopyrrolate, 82983-428 — Glycopyrrolate, 84549-203 — Glycopyrrolate, 84549-204 — Glycopyrrolate, 84549-205 — Glycopyrrolate, 84549-543 — glycopyrrolate, 86211-113 — Glycopyrrolate, +177 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.